Clinical Trials Browser

Terminated × Triple Negative Breast Neoplasms × Platinum × Clear all

NCT06351332 2026-06-04

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Phase 1 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms